Physician profile
Stanley Nabrinsky
NPI 1568459774
$153,811.21
in general payments reported to CMS, 2019-2025
79 companies · $13K in 2025
The $13K reported for 2025 was more than what 90% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42K · 2020: $21K · 2021: $15K · 2022: $21K · 2023: $15K · 2024: $26K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Food and Beverage: $9,989 · Honoraria: $9,200 · Travel and Lodging: $4,412 · Long Term Medical Supply Or Device Loan: $2,147 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Education: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $26,048.75 |
| Food and Beverage | $9,989.23 |
| Honoraria | $9,200.00 |
| Travel and Lodging | $4,411.70 |
| Long Term Medical Supply Or Device Loan | $2,147.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Education | $718.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $29,859.85 | 2019-2025 | Tecentriq, Alecensa, Venclexta |
| Astrazeneca Pharmaceuticals Lp | $17,945.69 | 2019-2025 | Imfinzi, Lynparza, Calquence |
| Blueprint Medicines Corporation | $16,590.11 | 2021-2025 | Ayvakit |
| Merck Sharp & Dohme LLC | $11,978.50 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Emd Serono, INC. | $10,981.54 | 2022-2024 | Tepmetko, Bavencio |
| Agios Pharmaceuticals, INC. | $6,945.79 | 2020-2025 | Pyrukynd |
| Pfizer INC. | $3,832.65 | 2019-2025 | |
| Janssen Biotech, INC. | $3,354.43 | 2019-2025 | Erleada, Rybrevant, Akeega |
| Novartis Pharmaceuticals Corporation | $3,286.21 | 2019-2025 | |
| Epizyme, INC. | $3,281.25 | 2022 | |
| Avyxa Pharma, LLC | $3,060.07 | 2025 | |
| Taiho Oncology, INC. | $3,037.13 | 2021-2024 | |
| Cti Biopharma Corp. | $2,797.49 | 2022-2023 | Vonjo |
| Beigene USA, INC. | $2,663.08 | 2023-2024 | Brukinsa |
| Takeda Pharmaceuticals U.S.A., INC. | $2,609.85 | 2019-2025 | Fruzaqla, Alunbrig, Iclusig |
Show all 79 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coherus Oncology, INC. | $2,300.00 | 2020-2021 | |
| Karyopharm Therapeutics INC. | $2,036.81 | 2021-2025 | Xpovio |
| Beone Medicines USA, INC. | $1,950.00 | 2025 | |
| Glaxosmithkline, LLC. | $1,901.30 | 2020-2025 | Jemperli, Zejula, Ojjaara |
| Eisai INC. | $1,640.71 | 2021-2025 | |
| Immunocore Limited | $1,615.19 | 2022-2025 | Kimmtrak |
| Celgene Corporation | $1,565.88 | 2020-2025 | Reblozyl, Pomalyst |
| Incyte Corporation | $1,558.67 | 2021-2024 | Monjuvi |
| Novocure INC. | $1,310.00 | 2019 | |
| Rigel Pharmaceuticals, INC. | $1,241.10 | 2022-2023 | Rezlidhia, Tavalisse |
| Daiichi Sankyo INC. | $1,228.72 | 2019-2025 | Vanflyta, Enhertu |
| Puma Biotechnology, INC. | $1,215.58 | 2019-2025 | |
| Abbvie INC. | $1,200.07 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $1,080.04 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $993.10 | 2019-2024 | Opdivo, Eliquis, Opdualag |
| Astellas Pharma US INC | $959.52 | 2020-2025 | Vyloy, Xtandi, Xospata |
| Eagle Pharmaceuticals, INC. | $850.00 | 2022 | |
| Adaptive Biotechnologies Corporation | $727.63 | 2020-2025 | Clonoseq |
| Lilly USA, LLC | $536.34 | 2019-2025 | Verzenio |
| Beigene, Ltd. | $450.00 | 2020 | |
| Janssen Pharmaceuticals, INC | $428.47 | 2019-2024 | Xarelto |
| Genzyme Corporation | $413.82 | 2019-2025 | |
| Tempus Ai, INC | $393.38 | 2024-2025 | Xt Cdx |
| Pharmacosmos Therapeutics INC. | $369.52 | 2022-2025 | Monoferric, Cosela |
| Gilead Sciences, INC. | $334.87 | 2021-2025 | Trodelvy |
| Seagen INC. | $304.07 | 2021-2023 | Adcetris, Padcev, Tukysa |
| Sobi, INC | $299.99 | 2024-2025 | |
| Cardinal Health 110 LLC | $225.00 | 2020-2025 | |
| Tersera Therapeutics LLC | $192.61 | 2023-2025 | Xermelo, Zoladex |
| Modernatx, INC. | $187.50 | 2022 | |
| Amgen INC. | $175.83 | 2020-2025 | Kyprolis |
| Regeneron Healthcare Solutions, INC. | $136.81 | 2021-2024 | Libtayo |
| Servier Pharmaceuticals LLC | $133.10 | 2023-2025 | |
| Array Biopharma INC | $128.01 | 2022-2025 | Braftovi, Mektovi, Lorbrena |
| Biocon Biologics INC | $112.83 | 2024-2025 | Ogivri, Yesintek, Fulphila |
| Myriad Genetic Laboratories, INC. | $111.14 | 2021-2023 | Myrisk |
| Bayer Healthcare Pharmaceuticals INC. | $102.46 | 2019-2024 | |
| Adc Therapeutics America, INC. | $101.44 | 2022-2023 | |
| G1 Therapeutics, INC. | $89.44 | 2022-2023 | Cosela |
| Morphosys, US INC. | $85.61 | 2022-2023 | Monjuvi |
| Alexion Pharmaceuticals, INC. | $79.99 | 2020-2025 | Ultomiris |
| Exelixis INC. | $79.50 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $77.67 | 2021-2022 | |
| Spectrum Pharmaceuticals INC. | $67.58 | 2023-2024 | Rolvedon |
| Secura Bio, INC. | $63.84 | 2021 | |
| Deciphera Pharmaceuticals INC. | $48.61 | 2023-2025 | Qinlock, Romvimza |
| Accord Healthcare, INC. | $47.85 | 2024-2025 | |
| Genmab U.S., INC. | $43.83 | 2024-2025 | Epkinly |
| Clovis Oncology, INC. | $43.65 | 2021-2022 | |
| Aveo Pharmaceuticals, INC. | $30.59 | 2023-2024 | Fotivda |
| Progenics Pharmaceuticals, INC. | $28.84 | 2025 | |
| Fennec Pharmaceuticals, INC. | $28.75 | 2024 | Pedmark |
| Mirati Therapeutics, INC. | $27.99 | 2024 | Krazati |
| Syndax Pharmaceuticals, INC. | $25.76 | 2025 | |
| Myovant Sciences INC. | $25.06 | 2022 | |
| Ge Healthcare | $25.05 | 2024 | |
| Organon LLC | $24.25 | 2023 | Ontruzant |
| Mylan Institutional INC. | $23.48 | 2023 | Hulio |
| Azurity Pharmaceuticals, INC. | $20.67 | 2025 | Vivimusta, Danziten |
| Menarini Silicon Biosystems, INC. | $20.04 | 2025 | |
| Verastem, INC. | $19.94 | 2020 | |
| Immunogen, INC. | $17.29 | 2023 | Elahere |
| Kite Pharma, INC. | $16.98 | 2022 | |
| Blue Earth Diagnostics | $13.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Nabrinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.